ML23104A062: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter:[7590-01-P] | {{#Wiki_filter:[7590-01-P] | ||
NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice AGENCY: U.S. Nuclear Regulatory Commission ACTION: Notice of Meeting. | |||
NUCLEAR REGULATORY COMMISSION | |||
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice | |||
AGENCY: U.S. Nuclear Regulatory Commission | |||
ACTION: Notice of Meeting. | |||
==SUMMARY== | ==SUMMARY== | ||
: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on May 15-16, 2023. A sample of agenda items to be discussed during the public session includes: an overview of medical related events; status update on the limited revisions to the abnormal occurrence criteria; a discussion of the potential impacts of the | : The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the | ||
Advisory Committee on the Medical Uses of Isotopes (ACMUI) on May 15-16, 2023. A sample | |||
of agenda items to be discussed during the public session includes: an overview of medical | |||
related events; status update on the limited revisions to the abnormal occurrence criteria; a | |||
discussion of the potential impacts of the Amer ican Board of Radiologys request to cease NRC | |||
recognition of their board certification processes; an overview of the current rulemaking to | |||
require reporting of certain nuclear medicine injection extravasations; and a review of the draft | |||
proposed rule for decommissioning financial assurance for sealed and unsealed radioactive | |||
materials. The agenda is subject to change. The current agenda and any updates will be | |||
available on the ACMUIs Meetings and Related Documents web page at | |||
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html or by e-mailing Dr. | |||
Celimar Valentin-Rodriguez at the contact information below. | Celimar Valentin-Rodriguez at the contact information below. | ||
==Purpose:== | ==Purpose:== | ||
Discuss issues related to 10 CFR Part 35, Medical Use of Byproduct Material. | Discuss issues related to 10 CFR Part 35, Medical Use of Byproduct Material. | ||
session will be closed to conduct the ACMUIs biennial evaluation and presentations for new ACMUI members. | Date and Time for Open Sessions : May 15, 2023, from 8:30 a.m. to 5:00 p.m. EDT. | ||
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North Building, Commissioners Hearing Room, 11555 Rockville Pike, Rockville, Maryland 20852. | |||
Date | Date and Time for Closed Session: May 16, 2023, from 9:00 p.m. to 12:00 p.m. EDT. This session will be closed to conduct the ACMUIs biennial evaluation and presentations for new | ||
May 15, 2023 | |||
ACMUI members. | |||
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North | |||
Building, Commissioners Hearing Room, 11555 Rockville Pike, Rockville, Maryland 20852. | |||
Date Webinar Information (Microsoft Teams) | |||
May 15, 2023 Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjczZTBhYTAtMDE2Ny00YjI3LWI4MGYtZTBkNm QyY2MzYWQw%40thread.v2/0?context=%7b%22Tid%22%3a%22e8 d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%225b3cab2a-da77-46d1-b0df-ca02d21f6361%22%7d | |||
Meeting ID: 274 828 149 496 Passcode: eX9sqR | |||
Call in number (audio only): +1 301-576-2978 (Silver Spring, MD, US) | |||
Phone Conference ID: 571 779 324# | Phone Conference ID: 571 779 324# | ||
PUBLIC PARTICIPATION: Any member of the public who wishes to participate in the meeting in person, via Microsoft Teams, or via phone should contact Dr. Valentin-Rodriguez using the information below. Members of the public | |||
CONTACT INFORMATION: Dr. Celimar Valentin-Rodriguez, e-mail: cvr2@nrc.gov Conduct of the Meeting The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: | PUBLIC PARTICIPATION: Any member of the public who wishes to participate in the meeting | ||
in person, via Microsoft Teams, or via phone should contact Dr. Valentin-Rodriguez using the | |||
information below. Members of the public s hould also monitor the NRCs Public Meeting | |||
Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. | |||
CONTACT INFORMATION: Dr. Celimar Valentin-Rodriguez, e-mail: cvr2@nrc.gov | |||
Conduct of the Meeting | |||
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr. Metter will | |||
conduct the meeting in a manner that will facilitate the orderly conduct of business. The | |||
following procedures apply to public participation in the meeting: | |||
: 1. Persons who wish to provide a written statement should submit an electronic copy to Dr. | : 1. Persons who wish to provide a written statement should submit an electronic copy to Dr. | ||
Celimar Valentin-Rodriguez using the contact information listed above. All submittals must be received by the close of business on May 9, 2023, and must only pertain to the topics on the agenda. | |||
: 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair. | Celimar Valentin-Rodriguez using the contact information listed above. All submittals | ||
: 3. The draft transcript and meeting summary will be available on ACMUIs website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html on or about June 30, 2023. | |||
: 4. Persons who require special services, such as those for the hearing impaired, should notify Dr. Celimar Valentin-Rodriguez of their planned participation. | must be received by the close of business on May 9, 2023, and must only pertain to the | ||
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7. This meeting notice is late because the NRC needed additional | |||
topics on the agenda. | |||
: 2. Questions and comments from members of the public will be permitted during the | |||
meeting, at the discretion of the ACMUI Chair. | |||
: 3. The draft transcript and meeting summary will be available on ACMUIs website | |||
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html on or about | |||
June 30, 2023. | |||
: 4. Persons who require special services, such as those for the hearing impaired, should | |||
notify Dr. Celimar Valentin-Rodriguez of their planned participation. | |||
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended | |||
(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the | |||
Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7. This meeting | |||
notice is late because the NRC needed additional ti me to ensure that the closed session met | |||
the Federal Advisory Committee Act guidelines. | |||
Dated at Rockville, Maryland this 1st day of May, 2023. | Dated at Rockville, Maryland this 1st day of May, 2023. | ||
For the U.S. Nuclear Regulatory Commission. | For the U.S. Nuclear Regulatory Commission. | ||
Russell E. Chazell, Federal Advisory Committee Management Officer.}} | |||
Revision as of 19:52, 14 November 2024
| ML23104A062 | |
| Person / Time | |
|---|---|
| Issue date: | 05/01/2023 |
| From: | Russell Chazell NRC/SECY/RAS |
| To: | |
| C Valentin-Rodriguez | |
| References | |
| Download: ML23104A062 (3) | |
Text
[7590-01-P]
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
AGENCY: U.S. Nuclear Regulatory Commission
ACTION: Notice of Meeting.
SUMMARY
- The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the
Advisory Committee on the Medical Uses of Isotopes (ACMUI) on May 15-16, 2023. A sample
of agenda items to be discussed during the public session includes: an overview of medical
related events; status update on the limited revisions to the abnormal occurrence criteria; a
discussion of the potential impacts of the Amer ican Board of Radiologys request to cease NRC
recognition of their board certification processes; an overview of the current rulemaking to
require reporting of certain nuclear medicine injection extravasations; and a review of the draft
proposed rule for decommissioning financial assurance for sealed and unsealed radioactive
materials. The agenda is subject to change. The current agenda and any updates will be
available on the ACMUIs Meetings and Related Documents web page at
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html or by e-mailing Dr.
Celimar Valentin-Rodriguez at the contact information below.
Purpose:
Discuss issues related to 10 CFR Part 35, Medical Use of Byproduct Material.
Date and Time for Open Sessions : May 15, 2023, from 8:30 a.m. to 5:00 p.m. EDT.
Date and Time for Closed Session: May 16, 2023, from 9:00 p.m. to 12:00 p.m. EDT. This session will be closed to conduct the ACMUIs biennial evaluation and presentations for new
ACMUI members.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North
Building, Commissioners Hearing Room, 11555 Rockville Pike, Rockville, Maryland 20852.
Date Webinar Information (Microsoft Teams)
May 15, 2023 Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjczZTBhYTAtMDE2Ny00YjI3LWI4MGYtZTBkNm QyY2MzYWQw%40thread.v2/0?context=%7b%22Tid%22%3a%22e8 d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%225b3cab2a-da77-46d1-b0df-ca02d21f6361%22%7d
Meeting ID: 274 828 149 496 Passcode: eX9sqR
Call in number (audio only): +1 301-576-2978 (Silver Spring, MD, US)
Phone Conference ID: 571 779 324#
PUBLIC PARTICIPATION: Any member of the public who wishes to participate in the meeting
in person, via Microsoft Teams, or via phone should contact Dr. Valentin-Rodriguez using the
information below. Members of the public s hould also monitor the NRCs Public Meeting
Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
CONTACT INFORMATION: Dr. Celimar Valentin-Rodriguez, e-mail: cvr2@nrc.gov
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr. Metter will
conduct the meeting in a manner that will facilitate the orderly conduct of business. The
following procedures apply to public participation in the meeting:
- 1. Persons who wish to provide a written statement should submit an electronic copy to Dr.
Celimar Valentin-Rodriguez using the contact information listed above. All submittals
must be received by the close of business on May 9, 2023, and must only pertain to the
topics on the agenda.
- 2. Questions and comments from members of the public will be permitted during the
meeting, at the discretion of the ACMUI Chair.
- 3. The draft transcript and meeting summary will be available on ACMUIs website
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html on or about
June 30, 2023.
- 4. Persons who require special services, such as those for the hearing impaired, should
notify Dr. Celimar Valentin-Rodriguez of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended
(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the
Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7. This meeting
notice is late because the NRC needed additional ti me to ensure that the closed session met
the Federal Advisory Committee Act guidelines.
Dated at Rockville, Maryland this 1st day of May, 2023.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell, Federal Advisory Committee Management Officer.